The Phase 3 study evaluated orforglipron, an investigational, once-daily oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist, for weight maintenance over 52 weeks after initial treatment for 72 weeks with the highest tolerated doses of Wegovy (semaglutide) or Zepbound (tirzepatide), in participants from SURMOUNT-5 who were offered the opportunity to be re-randomized to receive orforglipron or placebo
Natural-Looking Enhancement : The hyaluronic acid in JUVDERM binds with water molecules in the skin, creating a smooth, natural-looking volume in the treated areas
Born in Indianapolis, Indiana, Habener spent his early childhood in Park Ridge Illinois, a suburb of Chicago
What happens if you miss a dose of semaglutide
Murphy MG, Plunkett LM, Gertz BJ, et al
Forward primer 53: GCAGGCTTAGATCCACAATCTTCCACAG